RecruitingPhase 2NCT06088030
Arsenic Trioxide Combined With Chemotherapy for the Treatment of p53-mutated Pediatric Cancer
Studying Li-Fraumeni syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Yang Li
- Principal Investigator
- Yang Li, ProfessorSun Yat-Sen Memorial Hospital of Sun Yat-Sen University
- Intervention
- Arsenic trioxide(drug)
- Enrollment
- 50 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2023 – 2031
Study locations (1)
- Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China
Collaborators
Ruijin Hospital
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06088030 on ClinicalTrials.govOther trials for Li-Fraumeni syndrome
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT06712095Video Capsule Examination in Patients With Lynch SyndromeRoyal Marsden NHS Foundation Trust
- RECRUITINGNCT05126810Willingness to Participate in a Trial Comparing Standard Genetic Counseling Versus Personalized Genetic CounselingM.D. Anderson Cancer Center
- RECRUITINGNCT04541654Li-Fraumeni & TP53 (LiFT UP): Understanding and ProgressDana-Farber Cancer Institute
- RECRUITINGNCT04982744Registry of Li Fraumeni and Li Fraumeni Like SyndromesIstituto Ortopedico Rizzoli
- RECRUITINGNCT04367246Li-Fraumeni Syndrome/TP53 BiobankAbramson Cancer Center at Penn Medicine
- ENROLLING BY INVITATIONNANCT03176836Li-Fraumeni Syndrome Imaging StudyThe Hospital for Sick Children
- ACTIVE NOT RECRUITINGNANCT02950987Screening With Whole Body MRI For Detection Of Primary Tumors In Children And Adults With Li-Fraumeni Syndrome (LFS) And Other Cancer Predisposition SyndromesDana-Farber Cancer Institute
- RECRUITINGNANCT01443468Clinical and Genetic Studies of Li-Fraumeni SyndromeNational Cancer Institute (NCI)